EOLS - Evolus Inc logo

Evolus Inc

EOLS
Revenue grew 100% of years5Y
Compare EOLS Hold

Evolus Inc. develops aesthetic products for the cash-pay market, including Jeuveau, a botulinum toxin formulation for glabellar lines, and Evolysse, a range of hyaluronic acid injectables targeting facial areas like lips and cheeks across several regions.

โš•๏ธ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago โ†’$909today

Score Overview

1 Year
Score
Net Growth33.52%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth6.50%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score6.4
Net Growth26.65%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth217.53%
Rev TrendEvery year
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth26.74%
Net Trend50%
Net Income Consistency
Rev Growthโ€”
Rev TrendEvery year
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Evolus Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. EOLS does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 7.41โ€”
1 Year2025-10-22
$ 6.828.65%
5 Years2021-10-22
$ 8.15-9.08%
All Time2018-02-08
$ 11.50-35.57%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 316M-$ 34M$ 45M
2025$ 297M-$ 51M$ 53M
2024$ 266M-$ 50M$ 86M
2023$ 202M-$ 61M$ 62M
2022$ 148M-$ 74M$ 53M
2021$ 99M-$ 46M$ 146M
2020$ 56M-$ 163M$ 107M
2019$ 34M-$ 90M$ 129M
IPO2018$ 0.00-$ 46M$ 93M
EOLS - Evolus Inc logo

Evolus Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 56M to $ 297M and net income went from -$ 163M to -$ 51M. Revenue increased in every one of those 5 years; net income in 3.

Evolus Inc currently holds a 5-year HDB Score of 6.4 out of 10. How the HDB Score is calculated.

Membership

Explore EOLS with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies